Fluoropyrimidine usage in cases with hyperammonemia: real-world data study using the Japanese Adverse Drug Event Report (JADER) database.
Mitsuaki OuraFumiya OguroNobukazu AgatsumaHirotaka ImamakiYoshitaka NishikawaPublished in: Cancer chemotherapy and pharmacology (2023)
Hyperammonemia cases were more likely to be reported with intravenous fluorouracil than orally administered fluoropyrimidines. Fluoropyrimidines might interact with CKD in hyperammonemia cases.